Skip to main content
C

CELLUMED CO., LTD. — Investor Relations & Filings

Ticker · 049180 ISIN · KR7049180003 KO Manufacturing
Open in API
Filings indexed 396 across all filing types
Latest filing 2021-03-25 Delisting Announcement
Country KR South Korea
Listing KO 049180

About CELLUMED CO., LTD.

http://www.clnzyme.co.kr/

CELLUMED CO., LTD. is a biotechnology company specializing in the development and manufacturing of medical devices, tissue grafts, and advanced biologics. The company operates as a human tissue bank, producing and supplying a variety of bone graft materials, including allografts and xenografts, for transplantation. Its medical device portfolio features orthopedic implants, with a key product being an artificial knee joint system. In the biologics sector, Cellumed develops growth factors and provides specialized enzymes, such as CLnZyme, which are utilized in the research, development, and production of RNA-based vaccines and therapeutics.

Recent filings

Filing Released Lang Actions
주권매매거래정지해제(기업심사위원회 심의결과 상장폐지 기준 미해당)
Delisting Announcement Classification · 1% confidence The document is a short regulatory notice regarding the lifting of a trading suspension for Cellumed. It cites specific KOSDAQ market regulations and provides the effective date for the resumption of trading. Since it is a regulatory announcement regarding market status rather than a financial report, M&A activity, or share issuance, it falls under the general regulatory filings category.
2021-03-25 Korean
소속부변경
Regulatory Filings Classification · 1% confidence The document is a short, structured announcement regarding a change in the company's market classification (from 'Management/Administrative' to 'Venture Enterprise') on the stock exchange. It does not fit into specific financial reporting categories like 10-K or IR, nor is it a report publication announcement. As it is a regulatory notification regarding company status, it falls under the general regulatory filings category.
2021-03-25 Korean
감사보고서제출
Audit Report / Information Classification · 1% confidence The document is a formal 'Audit Report Submission' (감사보고서 제출) filed by the company Cellumed. It contains detailed financial tables including consolidated and separate financial statements, audit opinions, and key financial metrics (assets, liabilities, equity, revenue, profit/loss). While it is an announcement of the audit report, in the context of Korean regulatory filings (DART/KIND), this specific format is the standard disclosure for the annual audit results, which serves as the primary financial disclosure for the fiscal year. Given the comprehensive financial data provided, it is classified as an Audit Report/Information. FY 2020
2021-03-22 Korean
사업보고서 (2020.12)
Annual Report Classification · 1% confidence The document is a '사업보고서' (Business Report) from the company 'Cellumed'. In the South Korean regulatory context, a '사업보고서' is the equivalent of an Annual Report (10-K), as it contains comprehensive information including company overview, history, capital changes, management, and financial data for the fiscal year. It is not an announcement or a summary, but the full report itself. FY 2020
2021-03-22 Korean
[기재정정]주주총회소집공고
AGM Information Classification · 1% confidence The document is a 'Notice of General Meeting of Shareholders' (주주총회소집공고) for Cellumed. It contains the agenda for the 36th Annual General Meeting, including reports on business, financial statements, election of directors and auditors, and remuneration limits. It also includes detailed management information regarding business operations, market status, and governance (사외이사 활동내역, 최대주주 거래내역). This document is a formal proxy statement and information circular provided to shareholders to solicit votes for the upcoming meeting, which fits the definition of a Proxy Solicitation & Information Statement.
2021-03-16 Korean
의결권대리행사권유참고서류
Proxy Solicitation & Information Statement Classification · 1% confidence The document is titled '의결권대리행사권유참고서류' (Reference Document for Solicitation of Proxy), which is a standard regulatory filing in South Korea used by companies to solicit shareholder votes for an upcoming Annual General Meeting (AGM). It contains details about the meeting date, agenda items (such as approval of financial statements), and instructions for electronic voting. This falls under the category of Proxy Solicitation & Information Statement.
2021-03-16 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.